DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic

DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic

<p>Abstract</p> <p>Background</p> <p>The clinical effects of varying pharmacokinetic exposures of antibiotics (antibacterials and antifungals) on outcome in infected critically ill patients are poorly described. A large-scale multi-centre study (DALI Study) is currently...

Full description

Bibliographic Details
Main Authors: Roberts Jason A, De Waele Jan J, Dimopoulos George, Koulenti Despoina, Martin Claude, Montravers Philippe, Rello Jordi, Rhodes Andrew, Starr Therese, Wallis Steven C, Lipman Jeffrey
Format: Article
Language:English
Published: BMC 2012-07-01
Series:BMC Infectious Diseases
Subjects:
Antibiotic
βeta-lactam
Glycopeptide
Triazole
Echinocandin
Continuous infusion
Extended infusion
Bolus dosing
Adverse events
Pharmacokinetics
Pharmacodynamics
Online Access:http://www.biomedcentral.com/1471-2334/12/152

Internet

http://www.biomedcentral.com/1471-2334/12/152

Similar Items